“Emerging startups like Immobazyme, Sawubona Mycelium, and PhagoFlux are reshaping South Africa’s biotech sector with enzyme engineering, bioactive discovery, and AI-driven cellular health.”
South Africa’s biotech startup ecosystem is thriving, with companies like Immobazyme, Sawubona Mycelium, and PhagoFlux leading innovation.
Immobazyme, founded in 2019, specializes in immobilized enzyme engineering, developing sustainable technologies for industrial applications. Its patent-pending PepTrap™ technology exemplifies South African ingenuity in enzyme immobilization.
Sawubona Mycelium is pioneering bioactive ingredient discovery using mycelium fermentation. Its platform produces biodegradable, high-performance compounds for personal care, biomedical, and food industries, offering sustainable alternatives to petrochemical-derived ingredients.
PhagoFlux, a deep-tech startup, quantifies autophagy flux using AI-assisted microscopy. This breakthrough enables measurement of cellular health, longevity potential, and disease risk, transforming preventive healthcare.
Together, these startups highlight South Africa’s role as a biotech innovation hub, combining sustainability, advanced science, and global competitiveness.
